Bottom line
- Total investment $181K – $278K including a $50K franchise fee, 6.0% ongoing royalty.
- No Item 19 financial performance data disclosed — the franchisor chose not to publish revenue figures.
- Rated CAUTION with a risk score of 72/100.
- Auditor disclosed a going-concern note — flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.
Item 1 · who you're contracting with
The Franchisor
Yale framework · single-unit ROIC
Returns Analysis
Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.
The model · Yale framework
What would one AumBio unit return on the cash you put in?
Unlevered ROIC · per unit
46%
In Yale's "attractive" band (30–60%)
Overview
About
AumBio franchisees appear to operate wellness/health-related service locations, likely involving biohacking, nutrition, or alternative health offerings. Daily operations presumably include client consultations, service delivery, and retail/product sales, though the exact service model is unclear given the regulatory issues surrounding unsubstantiated health claims.
Item 7 · what it costs
The Vitals
Item 19
Financial Performance
This franchisor did not disclose financial performance representations in Item 19, or our extractor could not parse them.
Item 20 · unit dynamics
The Growth Chart
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 20 · 14 states with active franchisees
The Territory Map
Derived from franchisee contact records. Shows states with at least one current operator — not where the franchisor is registered to sell new units (that data is re-extracting in a future refresh).
States derived from franchisee phone area codes (Item 20). Approximate — ported numbers may show the original state, not the franchisee's current location.
Government records
SBA Loan Data
Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17
Risk & Legal
AumBio presents HIGH RISK due to recent regulatory cease-and-desist order for health marketing violations, critically small and opaque unit base, complete absence of financial disclosure, and franchisor going concern status.
Score breakdown · what drove the 72 / 100 rating
- 01MINORIllinois Cease and Desist order (April 2024) against franchisor principals for unsupported health claims and regulatory violations regarding medical status misrepresentation
- 02MEDExtremely small unit count (only 3 locations) with no disclosed growth trajectory, suggesting minimal system traction or viability
- 03MEDFinancial performance completely non-disclosed: zero transparency on average unit volumes, profitability, or franchisee ROI metrics
- 04MINORHigh initial investment ($180-278K) combined with 10-year commitment and 6% royalties with no revenue benchmarks to assess break-even feasibility
- 05HIGHGoing Concern status indicates potential financial instability of franchisor despite recent regulatory action
- 06MINORNo Item 19 (average unit economics) in FDD suggests franchisor unable or unwilling to provide performance data
Severity inferred from the FDD text · not a regulatory classification
FDD Items 5, 6, 12, 17 · continued from Risk & Legal
Contract & Territory Detail
Item 11
Training & Operations
Item 20
Franchisee Contacts
Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.
Franchisee contacts
14 numbers
One-time purchase · CSV download · Validation questions included
FDD download
AumBio · FDD (2026) PDF